Exploratory disproportionality analysis of potentially drug-induced eosinophilic pneumonia using United States Food and Drug Administration adverse event reporting system
Abstract Drug-induced eosinophilic pneumonia (EP) is an uncommon adverse drug reaction. Many drugs have been reported to cause EP, the evidence mainly being in the form of case reports/case series. This study aims to conduct an exploratory analysis of the United States Food and Drug Administration a...
Saved in:
Main Author: | Ashwin Kamath |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-85681-0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Scoping Review of Eosinophilic Pneumonia and Antidepressants: An Association Not to Be Overlooked
by: Jaron Steiner, et al.
Published: (2025-01-01) -
Eosinophilic Perimyositis In a Young Male: A Case Report and Review of Literature
by: Bimal Patel
Published: (2025-02-01) -
Eosinophilic pancreatitis: a rare or unexplored disease entity?
by: Murli Manohar, et al.
Published: (2020-03-01) -
Eosinophil is a predictor of severe immune-related adverse events induced by ipilimumab plus nivolumab therapy in patients with renal cell carcinoma: a retrospective multicenter cohort study
by: Yoshihiko Tasaki, et al.
Published: (2025-01-01) -
Serum and urine eosinophil-derived neurotoxin (EDN) levels predict biologic response in severe asthma
by: Yu Ri Kang, MD, et al.
Published: (2025-01-01)